is it safe to stay on semaglutide long term Do You Have Tirzepatide for Life? Treatment Duration Explained Are GLP-1s here to stay?

This date is determined based on stability studies, compounding conditions, and regulatory guidelines

The most frequent adverse events associated with resmetirom were diarrhea and nausea

Retatrutide is an investigational medication not approved by the FDA as of April 2026

Results Fifteen interviews were completed (n=5 with research associates, n=5 scientific project managers, n=5 principal investigators)

( Epub 2017 Oct 26 PMID: 29072533 ) Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

For the latest timeline, see when will retatrutide be available